Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | BDH1 |
| Upstream (Parents) |
|---|
| (<<) HMGCL → BDH1 |
| (<<) F12 → BDH1 |
| (<<) PXMP2 → BDH1 |
| Downstream (Children) |
|---|
| BDH1 → ASL (>>) |
| BDH1 → NR1I2 (>>) |
| BDH1 → SLC35D1 (>>) |
| BDH1 → CDHR2 (>>) |
| BDH1 → ALDH6A1 (>>) |
| BDH1 → ZBED2 (>>) |
| BDH1 → NR0B2 (>>) |
| BDH1 → ACSM3 (>>) |
| BDH1 → CYP3A5 (>>) |
| BDH1 → PEX11A (>>) |
| BDH1 → SIM1 (>>) |
| BDH1 → CES2 (>>) |
| BDH1 → FGGY (>>) |
| BDH1 → TST (>>) |
| BDH1 → C4orf34 (>>) |
| BDH1 → AGFG2 (>>) |
| BDH1 → ASS1 (>>) |
| BDH1 → VIPR1 (>>) |
| BDH1 → C4orf19 (>>) |
| BDH1 → AKR7A3 (>>) |
| BDH1 → HMP19 (>>) |
| BDH1 → CYP2J2 (>>) |
